Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI)

Kathleen J. Yost*, Susan E. Yount, David T. Eton, Cheryl Silberman, Anne Broughton-Heyes, David Cella

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

We assessed the reliability, validity, and responsiveness to change of the 6-item Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI) in a sample of 615 metastatic breast cancer patients. The FBSI is a brief, clinically relevant, and psychometrically sound instrument that can be used to measure symptoms in patients with breast cancer.

Original languageEnglish (US)
Pages (from-to)295-298
Number of pages4
JournalBreast Cancer Research and Treatment
Volume90
Issue number3
DOIs
StatePublished - Apr 2005

Funding

This work was supported by Eastern Cooperative Oncology Group grant CA 21115 E1193 and by an unrestricted grant from AstraZeneca.

Keywords

  • Breast cancer
  • Health-related quality of life
  • Meaningful differences
  • Reliability
  • Symptoms
  • Validity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI)'. Together they form a unique fingerprint.

Cite this